Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis - Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis -

Internal Medicine

Volumn 40, Issue 8, 2001, Pages 731-735

  Mezaki, Touru ^c   Chinushi, Masaomi ^b   Washizuka, Takashi ^c   Furushima, Hiroshi ^c   Chinushi, Yuuko ^a   Ebe, Katuya ^a   Okumura, Hiroshi ^c   Aizawa, Yoshifusa ^c  

^a NAGAOKA RED CROSS HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c NONE

Author keywords

Electrophysiologic study; ICD; Steroid therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DEFIBRILLATOR; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; SARCOIDOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR;

EID: 0035433403     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.731     Document Type: Article

References (8)

1. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med 63: 86-108, 1977.
2. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 82: 537-540, 1998.
3. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis; assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18: 937-943, 1991.
4. Okumura K, Olshansky B, Henthorn RW, Epstein AE, Plumb VJ, Waldo AL. Demonstration of the presence slow conduction during sustained ventricular tachycardia in man; use of transient entrainment of the tachycardia. Circulation 75: 369-378, 1987.
5. Chinushi M, Mezaki T, Aoki Y, Nakagawa I, Washizuka T, Aizawa Y. Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis. Jpn Circ J 64: 635-637, 2000.
6. Aizawa Y, Naitoh N, Kitazawa H, et al. Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. Am J Cardiol 72: 916-921, 1993.
7. Josephson ME. Recurrent ventricular tachycardia, in: Josephson ME, editor. Clinical Cardiac Electrophysiology. Philadelphia: Lea & Febiger, 1993: 417-615.
8. Platia EV, Reid PR. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation. J Am Coll Cardiol 4: 493-500, 1984.